Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01121939
Brief Title: Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers

First Submitted : May 10, 2010
First Submitted that Met QC Criteria : May 10, 2010
First Posted : May 12, 2010 (Estimate)

Results First Submitted : February 26, 2015
Results First Submitted that Met QC Criteria : August 20, 2015
Results First Posted : September 23, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : January 8, 2016
Last Update Posted : February 5, 2016 (Estimate)